SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Pharma rises on getting EIR with VAI for USA manufacturing facility

13 Apr 2026 Evaluate

Piramal Pharma is currently trading at Rs. 146.85, up by 0.75 points or 0.51% from its previous closing of Rs. 146.10 on the BSE.

The scrip opened at Rs. 144.15 and has touched a high and low of Rs. 147.45 and Rs. 140.85 respectively. So far 136144 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 228.45 on 23-Apr-2025 and a 52 week low of Rs. 132.50 on 23-Mar-2026.

Last one week high and low of the scrip stood at Rs. 147.45 and Rs. 137.30 respectively. The current market cap of the company is Rs. 19559.89 crore.

The promoters holding in the company stood at 34.86%, while Institutions and Non-Institutions held 45.35% and 19.79% respectively.

Piramal Pharma has received Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) from U.S. Food and Drug Administration (USFDA) for its manufacturing facility located at Lexington, (Kentucky, USA). The receipt of said EIR marks successful closure of the inspection.

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.

Piramal Pharma Share Price

146.50 0.40 (0.27%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×